NCT01316861View on ClinicalTrials.gov

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL

Enrollment

79

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

EMS Acarbose

EMS Acarbose 50 mg 3 times a day

DRUG

Bayer Acarbose

Bayer Acarbose 50 mg 3 times a day

Trial Locations (1)

12.245-000

Marcio Antonio Pereira Clinica, São José dos Campos

Sponsors

Lead Sponsor

All Listed Sponsors

lead

EMS

INDUSTRY

NCT01316861 - Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter